deltatrials
Completed PHASE3 NCT00669487

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand

Conditions HIV Infections
Interventions AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
Updated 6 times since 2017 Last updated: May 27, 2015 Started: Apr 30, 2008 Primary completion: Dec 31, 2010 Completion: Apr 30, 2011

A PHASE3 clinical study on HIV Infections, this trial is completed. The trial is conducted by Queen Savang Vadhana Memorial Hospital, Thailand and has accumulated 6 data snapshots since 2008. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Aug 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Aug 2023 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Queen Savang Vadhana Memorial Hospital, Thailand
  • SEARCH Research Foundation
  • Thai Red Cross AIDS Research Centre
  • University of Hawaii
Data source: SEARCH Research Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bangkok, Thailand